# Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline

> **NCT05109000** · PHASE4 · UNKNOWN · sponsor: **Jeffrey Alan Klein, MD** · enrollment: 32 (estimated)

## Conditions studied

- Injection Site Irritation
- Injection Site Bruising
- Injection Site Discomfort
- Benzoic Acid Adverse Reaction
- Anesthesia, Local

## Interventions

- **DRUG:** Sodium Chloride 0.9% Inj
- **DRUG:** Bacteriostatic Sodium Chloride 0.9 % INJECTION VIAL (ML)

## Key facts

- **NCT ID:** NCT05109000
- **Lead sponsor:** Jeffrey Alan Klein, MD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11
- **Primary completion:** 2022-01
- **Final completion:** 2022-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2021-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05109000

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05109000, "Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT05109000. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*